Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

$ENTB - Entest Biomedical News-Advancement Made - Cancer - Pet Lovers

|Includes: Entest BioMedical Inc. (ENTB)

(OTCPK:ENTB) http://www.zandertherapeutics.com/SOURCE Entest BioMedical Inc.

ENTB is a Biomedical Healthcare company in the Developmental-R & D Stage

They are Licensed via the Parent company $RGBP Regen BioPharma, Inc.

http://www.regenbiopharmainc.com

Entest in turn licences Zander Therapeutics, Inc. for the purpose of researching, developing new Drugs/Treatment for Animals.

http://www.zandertherapeutics.com/SOURCE Entest BioMedical Inc.

PET LOVERS Are EXCITED !!!!!

Zander has made major breakthroughs with Horses-in especially Race Horses ($ENTB Announced Breakthroughs w/Race Horse ("Exercise Induced Pulmonary Hemorrhage (EIPH)." ) http://finance.yahoo.com/news/entest-biomedical-inc-subsidiary-zander-130000432.htm … ) and

Canines (Dogs) ($ENTB Breakthrough"Canine AutologusImmunotherapy using Dendritic Cells" from Dog Blood Kill Tumor Cells

https://lnkd.in/dpk_9dE )

Now $ENTB announces a New Breakthrough for Canines -

$ENTB Initiates Ex Vivo Studies on Modulating NR2F6 (Licensed to Zander Therapeutics)- Utilizing Canines Blood to Kill Cancer Compounds are similar to those used in Humans. Experiments use small amounts of blood drawn from the Donor animal, designed to see how closely Canine cells mimic Humans. The compounds are currently being developed for use in Humans by $RGBP (Licenses NR2F6 to ENTB)

For more on this Big News :

Entest BioMedical's Subsidiary, Zander Therapeutics, Inc., Initiates Ex Vivo Studies on Modulating NR2F6 in Canines

www.otcmarkets.com/stock/ENTB/news

We believe $ENTB is a Long Play and should get more attention. Take a Long look at this Stem Cell working to Help Pet Lovers.

ENTB can be a Short Term Gain-Profit as well as have been experienced in the past.

If you need more information-Have any Questions-Need an Accurate up to the Minute Bid/Ask (Most Brokers and B/D's are on a 15 Minute Delay-or can't see a Bid/Ask at all.)

Contact: Rob Kreh - Principal (Small cap Solutions, LLC. (robkreh@smallcapsolutions.com)

(OTCBB:RGBP) Disclaimer: You are receiving this because you have requested the information contained in this email, and/or have expressed an interest recently, or in the past to be included in such emails. And/or have requested information/news/updates for Entest Biomedical, Inc. This profile has been compiled by Small Cap Solutions, LLC based on information from the company believed to be true/factual. This profile is not guaranteed, neither implied, nor in writing, as to the accuracy and completeness of content, and prepared for information purposes only. As such, this profile may contain forward reaching statements, as defined in the Private Securities Litigation Act of 1995. Actual results could differ materially from the statements either expressed or implied herein. Prospective investors are advised to review the Company's periodic filings with the Securities and Exchange Commission or at www.otcmarkets.com. Small Cap Solutions, LLC has received ($1000.00) cash from Value Quest, Inc. for investor relations services rendered for Entest Biomedical, Inc. . Additional inquiries are available by email to robkreh@smallcapsolutions.com or in writing to Small Cap Solutions, LLC 303 Joppa Crossing Ct (Suite #1) Joppa, Md. 21085 This is not a solicitation to buy or sell securities. To "unsubscribe to this mailing list, please reply "unsubscribe" to this message.

Disclaimer: All Micro/Small Cap Company(ies) profile(s) are/have been compiled by Small Cap Solutions, LLC based on information believed to be true and gathered either from client companies and/or third party('s)/web sites. These profiles are not guaranteed, neither implied, nor in writing, as to the accuracy and completeness of content, and has been prepared for information purposes only. As such, this profile may contain forward reaching statements, as defined in the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from the statements either expressed or implied herein.

Prospective investors are advised to review the Company's periodic filings with the Securities and Exchange Commission or at yahoofinance.com and/or otcmarkets.com Small Cap Solutions, LLC may receive cash or stock from client companies for investor relations services rendered.

Small Cap Solutions, LLC and/or its Principal/Employees are not registered Broker(s)/Broker Dealer(s) with FINRA or the SEC. Small Cap Solutions, LLC does not make any buy/sell recommendations at any time, but may state their opinion on companies, etc. That is not meant to be a recommendation. All information disseminated by Small Cap Solutions, LLC is believed to be true and public. Additional inquiries available by email to robkreh@smallcapsolutions.comor by mail to 303 Joppa Crossing Ct. (Suite#1) Joppa, Md. 21085. To unsubscribe to this mailing list, please reply "unsubscribe" to this message or by mail to 303 Joppa Crossing Ct. (Suite#1) Joppa, Md. 21085. To unsubscribe to this mailing list, please reply "unsubscribe" to this message.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.